Seeking Alpha

GREENBROOK TMS REPORTS FIRST QUARTER OPERATIONAL AND FINANCIAL RESULTS

Operating through 130 Company-operated Treatment Centers, Greenbrook is a leading provider of TMS and Spravato®, FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder ...
Business Wire

Greenbrook TMS Reports Fiscal 2022 Operational and Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2022 (“Q4 2022”) and year-end 2022 (“Fiscal 2022”) operational and ...
Nasdaq

Greenbrook TMS Reports Revenue Growth and Merger Plans

The latest announcement is out from Greenbrook Tms ( (GBNHF)). Greenbrook TMS Inc. reported a 9% increase in quarterly service revenue for Q3 2024, reaching $18.9 million, despite operational ...

Moment of Clarity Publishes In-Depth Resource on Insurance Coverage for TMS Therapy, Expanding Access to Evidence-Based Mental Health Treatment

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...
Yahoo Finance

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation ...
Seeking Alpha

GREENBROOK TMS REPORTS SECOND QUARTER OPERATIONAL AND FINANCIAL RESULTS

View original content:https://www.prnewswire.com/news-releases/greenbrook-tms-reports-second-quarter-operational-and-financial-results-301900379.html SOURCE ...
Business Wire

Greenbrook TMS Reports Record Fiscal 2021 Operational and Financial Results

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2021 (“Q4 2021 ...